195 related articles for article (PubMed ID: 16809771)
1. BAL1 and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are overexpressed in diffuse large B-cell lymphomas with a prominent inflammatory infiltrate.
Juszczynski P; Kutok JL; Li C; Mitra J; Aguiar RC; Shipp MA
Mol Cell Biol; 2006 Jul; 26(14):5348-59. PubMed ID: 16809771
[TBL] [Abstract][Full Text] [Related]
2. BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFNγ-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma.
Camicia R; Bachmann SB; Winkler HC; Beer M; Tinguely M; Haralambieva E; Hassa PO
J Cell Sci; 2013 May; 126(Pt 9):1969-80. PubMed ID: 23487038
[TBL] [Abstract][Full Text] [Related]
3. BAL1 and its partner E3 ligase, BBAP, link Poly(ADP-ribose) activation, ubiquitylation, and double-strand DNA repair independent of ATM, MDC1, and RNF8.
Yan Q; Xu R; Zhu L; Cheng X; Wang Z; Manis J; Shipp MA
Mol Cell Biol; 2013 Feb; 33(4):845-57. PubMed ID: 23230272
[TBL] [Abstract][Full Text] [Related]
4. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response.
Monti S; Savage KJ; Kutok JL; Feuerhake F; Kurtin P; Mihm M; Wu B; Pasqualucci L; Neuberg D; Aguiar RC; Dal Cin P; Ladd C; Pinkus GS; Salles G; Harris NL; Dalla-Favera R; Habermann TM; Aster JC; Golub TR; Shipp MA
Blood; 2005 Mar; 105(5):1851-61. PubMed ID: 15550490
[TBL] [Abstract][Full Text] [Related]
5. Loss of interferon-gamma inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line.
Dovhey SE; Ghosh NS; Wright KL
Cancer Res; 2000 Oct; 60(20):5789-96. PubMed ID: 11059775
[TBL] [Abstract][Full Text] [Related]
6. Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomas.
Kobayashi T; Yamaguchi M; Kim S; Morikawa J; Ogawa S; Ueno S; Suh E; Dougherty E; Shmulevich I; Shiku H; Zhang W
Cancer Res; 2003 Jan; 63(1):60-6. PubMed ID: 12517778
[TBL] [Abstract][Full Text] [Related]
7. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
[TBL] [Abstract][Full Text] [Related]
8. B-aggressive lymphoma family proteins have unique domains that modulate transcription and exhibit poly(ADP-ribose) polymerase activity.
Aguiar RC; Takeyama K; He C; Kreinbrink K; Shipp MA
J Biol Chem; 2005 Oct; 280(40):33756-65. PubMed ID: 16061477
[TBL] [Abstract][Full Text] [Related]
9. BCL-6 in diffuse large-cell lymphomas.
Dalla-Favera R; Ye BH; Cattoretti G; Lo Coco F; Chang CC; Zhang J; Migliazza A; Cechova K; Niu H; Chaganti S; Chen W; Louie DC; Offit K; Chaganti RS
Important Adv Oncol; 1996; ():139-48. PubMed ID: 8791133
[No Abstract] [Full Text] [Related]
10. The TATA-containing core promoter of the type II collagen gene (COL2A1) is the target of interferon-gamma-mediated inhibition in human chondrocytes: requirement for Stat1 alpha, Jak1 and Jak2.
Osaki M; Tan L; Choy BK; Yoshida Y; Cheah KS; Auron PE; Goldring MB
Biochem J; 2003 Jan; 369(Pt 1):103-15. PubMed ID: 12223098
[TBL] [Abstract][Full Text] [Related]
11. The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma.
Ueda C; Akasaka T; Kurata M; Maesako Y; Nishikori M; Ichinohasama R; Imada K; Uchiyama T; Ohno H
Oncogene; 2002 Jan; 21(3):368-76. PubMed ID: 11821949
[TBL] [Abstract][Full Text] [Related]
12. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
13. HDAC1,2 inhibition impairs EZH2- and BBAP-mediated DNA repair to overcome chemoresistance in EZH2 gain-of-function mutant diffuse large B-cell lymphoma.
Johnson DP; Spitz GS; Tharkar S; Quayle SN; Shearstone JR; Jones S; McDowell ME; Wellman H; Tyler JK; Cairns BR; Chandrasekharan MB; Bhaskara S
Oncotarget; 2015 Mar; 6(7):4863-87. PubMed ID: 25605023
[TBL] [Abstract][Full Text] [Related]
14. DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells.
Bachmann SB; Frommel SC; Camicia R; Winkler HC; Santoro R; Hassa PO
Mol Cancer; 2014 May; 13():125. PubMed ID: 24886089
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD29 on lymphoma cells and/or CD36 on microvascular endothels correlates with high serum LDH level in diffuse large B-cell lymphomas (DLBCLs) and is frequent in de novo CD5-positive DLBCLs.
Ueno S; Yamaguchi M; Kimura M; Odagiri H; Shiraki K; Uemoto S; Nakamura N; Zhang W; Shiku H; Kobayashi T
Int J Oncol; 2005 Nov; 27(5):1241-6. PubMed ID: 16211218
[TBL] [Abstract][Full Text] [Related]
16. NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes.
Feuerhake F; Kutok JL; Monti S; Chen W; LaCasce AS; Cattoretti G; Kurtin P; Pinkus GS; de Leval L; Harris NL; Savage KJ; Neuberg D; Habermann TM; Dalla-Favera R; Golub TR; Aster JC; Shipp MA
Blood; 2005 Aug; 106(4):1392-9. PubMed ID: 15870177
[TBL] [Abstract][Full Text] [Related]
17. Primary testicular diffuse large B-cell lymphomas have activated B-cell-like subtype characteristics.
Booman M; Douwes J; Glas AM; de Jong D; Schuuring E; Kluin PM
J Pathol; 2006 Oct; 210(2):163-71. PubMed ID: 16823896
[TBL] [Abstract][Full Text] [Related]
18. T-cell protein tyrosine phosphatase, distinctively expressed in activated-B-cell-like diffuse large B-cell lymphomas, is the nuclear phosphatase of STAT6.
Lu X; Chen J; Sasmono RT; Hsi ED; Sarosiek KA; Tiganis T; Lossos IS
Mol Cell Biol; 2007 Mar; 27(6):2166-79. PubMed ID: 17210636
[TBL] [Abstract][Full Text] [Related]
19. Absence of the JAK2 V617F activating mutation in classical Hodgkin lymphoma and primary mediastinal B-cell lymphoma.
Melzner I; Weniger MA; Menz CK; Möller P
Leukemia; 2006 Jan; 20(1):157-8. PubMed ID: 16331280
[No Abstract] [Full Text] [Related]
20. Txk, a member of the non-receptor tyrosine kinase of the Tec family, forms a complex with poly(ADP-ribose) polymerase 1 and elongation factor 1alpha and regulates interferon-gamma gene transcription in Th1 cells.
Maruyama T; Nara K; Yoshikawa H; Suzuki N
Clin Exp Immunol; 2007 Jan; 147(1):164-75. PubMed ID: 17177976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
